Evidence map›Paper›PMID 35213299›Full record

ArticleMicrobiology (Reading, England)2022

Rare actinobacteria isolated from the hypersaline Ojo de Liebre Lagoon as a source of novel bioactive compounds with biotechnological potential.

Andrea Y Zamora-Quintero, Mónica Torres-Beltrán, Dulce G Guillén Matus, Irasema Oroz-Parra, Natalie Millán-Aguiñaga

Abstract read
In one paragraph

Article in Microbiology (Reading, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Frontiers in microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea Y Zamora-QuinteroFacultad de Ciencias Marinas, Universidad Autónoma de Baja California, Ensenada, Baja California, México.
Mónica Torres-BeltránFacultad de Ciencias Marinas, Universidad Autónoma de Baja California, Ensenada, Baja California, México.
Dulce G Guillén MatusScripps Institution of Oceanography, University of California, San Diego, La Jolla, California, USA.
Irasema Oroz-ParraFacultad de Ciencias Marinas, Universidad Autónoma de Baja California, Ensenada, Baja California, México.
Natalie Millán-AguiñagaFacultad de Ciencias Marinas, Universidad Autónoma de Baja California, Ensenada, Baja California, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ojo de Liebre Lagoon is a Marine Protected Area that lies within a UNESCO World Heritage Site and is a critical habitat for important migratory species such as the grey whale and bird species. Unique hypersaline environments, such as the Ojo de Liebre Lagoon, are underexplored in terms of their bacterial and chemical diversity, representing a potential source for new bioactive compounds with pharmacological properties. Actinobacteria are one of the most diverse and prolific taxonomic bacterial groups in terms of marine bioactive compounds. This study aimed to identify the culturable actinobacterial community inhabiting the Lagoon, as well as to test their potential as new sources of anticancer compounds with pharmacological potential. A selective isolation approach focused on spore-forming bacteria from 40 sediment samples generated a culture collection of 64 strains. The 16S rRNA gene analyses identified three phyla in this study, the Actinobacteria, Firmicutes and Proteobacteria, where the phylum Actinobacteria dominated (57%) the microbial community profiles. Within the Actinobacteria, nine different genera were isolated including the

Indexed as

ActinobacteriaStreptomycesBiodiversityCaco-2 CellsHumansPhylogenyRNA, Ribosomal, 16SRNA, Ribosomal, 16Sactinobacteriaanticancer activitysecondary metabolites

Identifiers

PMID35213299
PMCPMC8941997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.